Global Diagnostic Technology Market

Diagnostic Technology Comprehensive Study by Type (Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation and Hemostasis, Urinalysis, Other IVD Technologies), Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing/Pharmacogenomics, HIV/Aids, Others), End User (Hospitals, Laboratories, Point-Of-Care Testing, Patient Self-Testing, Academic Institutes, Others) Players and Region - Global Market Outlook to 2028

Diagnostic Technology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Identification of a disease, condition, disorder, or problem by systematic analysis of the background or history, examination of the signs or symptoms, evaluation of the research or test results, and investigation of the assumed or probable causes. Effective prognosis is not possible without an effective diagnosis. Diagnostic technology has been proven as the most effective technology in the field of healthcare and gained significant importance across the globe. Diagnostic technology has resolved many issues such as data errors, complexities, and other outcomes. It is aiming for escalating the volume of molecular insights and translating it into products with high medical significance for physicians and patients.This growth is primarily driven by Rising Geriatric Population .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Roche Diagnostics SpA (Italy), Danaher Corporation (United States), Abbott Laboratories, Inc. (United States), Siemens AG (United States), Sysmex Corporation (Japan), Thermo Fisher Scientific (United States), Becton, Dickinson, and Company (United States), Biomérieux SA (France), Bio-Rad Laboratories, Inc. (France) and Johnson & Johnson (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On June 2023, Quest Diagnostics , the nation's leading provider of diagnostic information services, had acquired Haystack Oncology. The acquisition Adding Sensitive MRD Liquid Biopsy Technology to Cancer Diagnostics Portfolio.
In November 2023, Roche has launched of the LightCycler® PRO System based on the proven gold standard technology of the LightCycler® Systems that came before it. This new system raises the bar for performance and usability while bridging the gap between translational research and in vitro diagnostics.The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Market Growth Drivers:
Rising Geriatric Population, The Rising Prevalence of Infectious and Chronic Diseases, Growing Awareness of Personalized Medicine, Increasing Adoption of Point-Of-Care Testing and Growing Awareness Regarding Preventive Care

Challenges:
Operational Obstacles Faced in Conducting Diagnostic Tests and Changing Regulatory Landscape

Restraints:
Critical Reimbursement Scenario

Opportunities:
Development of Condition-Specific Markers and Tests, Growing Importance of Companion Diagnostics and Emerging Demand from Economies

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Diagnostic Technology Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Diagnostic Technology Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Diagnostic Technology players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Diagnostic Technology Study Sheds Light on
— The Diagnostic Technology Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Diagnostic Technology industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Diagnostic Technology industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Immunoassay/Immunochemistry
  • Clinical Chemistry
  • Molecular Diagnostics
  • Microbiology
  • Hematology
  • Coagulation and Hemostasis
  • Urinalysis
  • Other IVD Technologies
By Application
  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Autoimmune Diseases
  • Nephrology
  • Drug Testing/Pharmacogenomics
  • HIV/Aids
  • Others
By End User
  • Hospitals
  • Laboratories
  • Point-Of-Care Testing
  • Patient Self-Testing
  • Academic Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Geriatric Population
      • 3.2.2. The Rising Prevalence of Infectious and Chronic Diseases
      • 3.2.3. Growing Awareness of Personalized Medicine
      • 3.2.4. Increasing Adoption of Point-Of-Care Testing
      • 3.2.5. Growing Awareness Regarding Preventive Care
    • 3.3. Market Challenges
      • 3.3.1. Operational Obstacles Faced in Conducting Diagnostic Tests
      • 3.3.2. Changing Regulatory Landscape
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Diagnostic Technology, by Type, Application, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Diagnostic Technology (Value)
      • 5.2.1. Global Diagnostic Technology by: Type (Value)
        • 5.2.1.1. Immunoassay/Immunochemistry
        • 5.2.1.2. Clinical Chemistry
        • 5.2.1.3. Molecular Diagnostics
        • 5.2.1.4. Microbiology
        • 5.2.1.5. Hematology
        • 5.2.1.6. Coagulation and Hemostasis
        • 5.2.1.7. Urinalysis
        • 5.2.1.8. Other IVD Technologies
      • 5.2.2. Global Diagnostic Technology by: Application (Value)
        • 5.2.2.1. Infectious Diseases
        • 5.2.2.2. Diabetes
        • 5.2.2.3. Oncology
        • 5.2.2.4. Cardiology
        • 5.2.2.5. Autoimmune Diseases
        • 5.2.2.6. Nephrology
        • 5.2.2.7. Drug Testing/Pharmacogenomics
        • 5.2.2.8. HIV/Aids
        • 5.2.2.9. Others
      • 5.2.3. Global Diagnostic Technology by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Laboratories
        • 5.2.3.3. Point-Of-Care Testing
        • 5.2.3.4. Patient Self-Testing
        • 5.2.3.5. Academic Institutes
        • 5.2.3.6. Others
      • 5.2.4. Global Diagnostic Technology Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Diagnostic Technology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Roche Diagnostics SpA (Italy)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Danaher Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abbott Laboratories, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens AG (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sysmex Corporation (Japan)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Thermo Fisher Scientific (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Becton, Dickinson, and Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Biomérieux SA (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bio-Rad Laboratories, Inc. (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Johnson & Johnson (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Diagnostic Technology Sale, by Type, Application, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Diagnostic Technology (Value)
      • 7.2.1. Global Diagnostic Technology by: Type (Value)
        • 7.2.1.1. Immunoassay/Immunochemistry
        • 7.2.1.2. Clinical Chemistry
        • 7.2.1.3. Molecular Diagnostics
        • 7.2.1.4. Microbiology
        • 7.2.1.5. Hematology
        • 7.2.1.6. Coagulation and Hemostasis
        • 7.2.1.7. Urinalysis
        • 7.2.1.8. Other IVD Technologies
      • 7.2.2. Global Diagnostic Technology by: Application (Value)
        • 7.2.2.1. Infectious Diseases
        • 7.2.2.2. Diabetes
        • 7.2.2.3. Oncology
        • 7.2.2.4. Cardiology
        • 7.2.2.5. Autoimmune Diseases
        • 7.2.2.6. Nephrology
        • 7.2.2.7. Drug Testing/Pharmacogenomics
        • 7.2.2.8. HIV/Aids
        • 7.2.2.9. Others
      • 7.2.3. Global Diagnostic Technology by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Laboratories
        • 7.2.3.3. Point-Of-Care Testing
        • 7.2.3.4. Patient Self-Testing
        • 7.2.3.5. Academic Institutes
        • 7.2.3.6. Others
      • 7.2.4. Global Diagnostic Technology Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Diagnostic Technology: by Type(USD Million)
  • Table 2. Diagnostic Technology Immunoassay/Immunochemistry , by Region USD Million (2017-2022)
  • Table 3. Diagnostic Technology Clinical Chemistry , by Region USD Million (2017-2022)
  • Table 4. Diagnostic Technology Molecular Diagnostics , by Region USD Million (2017-2022)
  • Table 5. Diagnostic Technology Microbiology , by Region USD Million (2017-2022)
  • Table 6. Diagnostic Technology Hematology , by Region USD Million (2017-2022)
  • Table 7. Diagnostic Technology Coagulation and Hemostasis , by Region USD Million (2017-2022)
  • Table 8. Diagnostic Technology Urinalysis , by Region USD Million (2017-2022)
  • Table 9. Diagnostic Technology Other IVD Technologies , by Region USD Million (2017-2022)
  • Table 10. Diagnostic Technology: by Application(USD Million)
  • Table 11. Diagnostic Technology Infectious Diseases , by Region USD Million (2017-2022)
  • Table 12. Diagnostic Technology Diabetes , by Region USD Million (2017-2022)
  • Table 13. Diagnostic Technology Oncology , by Region USD Million (2017-2022)
  • Table 14. Diagnostic Technology Cardiology , by Region USD Million (2017-2022)
  • Table 15. Diagnostic Technology Autoimmune Diseases , by Region USD Million (2017-2022)
  • Table 16. Diagnostic Technology Nephrology , by Region USD Million (2017-2022)
  • Table 17. Diagnostic Technology Drug Testing/Pharmacogenomics , by Region USD Million (2017-2022)
  • Table 18. Diagnostic Technology HIV/Aids , by Region USD Million (2017-2022)
  • Table 19. Diagnostic Technology Others , by Region USD Million (2017-2022)
  • Table 20. Diagnostic Technology: by End User(USD Million)
  • Table 21. Diagnostic Technology Hospitals , by Region USD Million (2017-2022)
  • Table 22. Diagnostic Technology Laboratories , by Region USD Million (2017-2022)
  • Table 23. Diagnostic Technology Point-Of-Care Testing , by Region USD Million (2017-2022)
  • Table 24. Diagnostic Technology Patient Self-Testing , by Region USD Million (2017-2022)
  • Table 25. Diagnostic Technology Academic Institutes , by Region USD Million (2017-2022)
  • Table 26. Diagnostic Technology Others , by Region USD Million (2017-2022)
  • Table 27. South America Diagnostic Technology, by Country USD Million (2017-2022)
  • Table 28. South America Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 29. South America Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 30. South America Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 31. Brazil Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 32. Brazil Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 33. Brazil Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 34. Argentina Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 35. Argentina Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 36. Argentina Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 37. Rest of South America Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 38. Rest of South America Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 39. Rest of South America Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 40. Asia Pacific Diagnostic Technology, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 42. Asia Pacific Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 43. Asia Pacific Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 44. China Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 45. China Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 46. China Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 47. Japan Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 48. Japan Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 49. Japan Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 50. India Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 51. India Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 52. India Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 53. South Korea Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 54. South Korea Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 55. South Korea Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 56. Taiwan Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 57. Taiwan Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 58. Taiwan Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 59. Australia Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 60. Australia Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 61. Australia Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 65. Europe Diagnostic Technology, by Country USD Million (2017-2022)
  • Table 66. Europe Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 67. Europe Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 68. Europe Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 69. Germany Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 70. Germany Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 71. Germany Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 72. France Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 73. France Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 74. France Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 75. Italy Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 76. Italy Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 77. Italy Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 78. United Kingdom Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 79. United Kingdom Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 80. United Kingdom Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 81. Netherlands Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 82. Netherlands Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 83. Netherlands Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 84. Rest of Europe Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 85. Rest of Europe Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 86. Rest of Europe Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 87. MEA Diagnostic Technology, by Country USD Million (2017-2022)
  • Table 88. MEA Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 89. MEA Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 90. MEA Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 91. Middle East Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 92. Middle East Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 93. Middle East Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 94. Africa Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 95. Africa Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 96. Africa Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 97. North America Diagnostic Technology, by Country USD Million (2017-2022)
  • Table 98. North America Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 99. North America Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 100. North America Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 101. United States Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 102. United States Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 103. United States Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 104. Canada Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 105. Canada Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 106. Canada Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 107. Mexico Diagnostic Technology, by Type USD Million (2017-2022)
  • Table 108. Mexico Diagnostic Technology, by Application USD Million (2017-2022)
  • Table 109. Mexico Diagnostic Technology, by End User USD Million (2017-2022)
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Diagnostic Technology: by Type(USD Million)
  • Table 121. Diagnostic Technology Immunoassay/Immunochemistry , by Region USD Million (2023-2028)
  • Table 122. Diagnostic Technology Clinical Chemistry , by Region USD Million (2023-2028)
  • Table 123. Diagnostic Technology Molecular Diagnostics , by Region USD Million (2023-2028)
  • Table 124. Diagnostic Technology Microbiology , by Region USD Million (2023-2028)
  • Table 125. Diagnostic Technology Hematology , by Region USD Million (2023-2028)
  • Table 126. Diagnostic Technology Coagulation and Hemostasis , by Region USD Million (2023-2028)
  • Table 127. Diagnostic Technology Urinalysis , by Region USD Million (2023-2028)
  • Table 128. Diagnostic Technology Other IVD Technologies , by Region USD Million (2023-2028)
  • Table 129. Diagnostic Technology: by Application(USD Million)
  • Table 130. Diagnostic Technology Infectious Diseases , by Region USD Million (2023-2028)
  • Table 131. Diagnostic Technology Diabetes , by Region USD Million (2023-2028)
  • Table 132. Diagnostic Technology Oncology , by Region USD Million (2023-2028)
  • Table 133. Diagnostic Technology Cardiology , by Region USD Million (2023-2028)
  • Table 134. Diagnostic Technology Autoimmune Diseases , by Region USD Million (2023-2028)
  • Table 135. Diagnostic Technology Nephrology , by Region USD Million (2023-2028)
  • Table 136. Diagnostic Technology Drug Testing/Pharmacogenomics , by Region USD Million (2023-2028)
  • Table 137. Diagnostic Technology HIV/Aids , by Region USD Million (2023-2028)
  • Table 138. Diagnostic Technology Others , by Region USD Million (2023-2028)
  • Table 139. Diagnostic Technology: by End User(USD Million)
  • Table 140. Diagnostic Technology Hospitals , by Region USD Million (2023-2028)
  • Table 141. Diagnostic Technology Laboratories , by Region USD Million (2023-2028)
  • Table 142. Diagnostic Technology Point-Of-Care Testing , by Region USD Million (2023-2028)
  • Table 143. Diagnostic Technology Patient Self-Testing , by Region USD Million (2023-2028)
  • Table 144. Diagnostic Technology Academic Institutes , by Region USD Million (2023-2028)
  • Table 145. Diagnostic Technology Others , by Region USD Million (2023-2028)
  • Table 146. South America Diagnostic Technology, by Country USD Million (2023-2028)
  • Table 147. South America Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 148. South America Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 149. South America Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 150. Brazil Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 151. Brazil Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 152. Brazil Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 153. Argentina Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 154. Argentina Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 155. Argentina Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 156. Rest of South America Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 157. Rest of South America Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 158. Rest of South America Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 159. Asia Pacific Diagnostic Technology, by Country USD Million (2023-2028)
  • Table 160. Asia Pacific Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 161. Asia Pacific Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 162. Asia Pacific Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 163. China Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 164. China Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 165. China Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 166. Japan Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 167. Japan Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 168. Japan Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 169. India Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 170. India Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 171. India Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 172. South Korea Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 173. South Korea Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 174. South Korea Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 175. Taiwan Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 176. Taiwan Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 177. Taiwan Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 178. Australia Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 179. Australia Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 180. Australia Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 181. Rest of Asia-Pacific Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 182. Rest of Asia-Pacific Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 183. Rest of Asia-Pacific Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 184. Europe Diagnostic Technology, by Country USD Million (2023-2028)
  • Table 185. Europe Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 186. Europe Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 187. Europe Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 188. Germany Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 189. Germany Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 190. Germany Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 191. France Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 192. France Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 193. France Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 194. Italy Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 195. Italy Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 196. Italy Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 197. United Kingdom Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 198. United Kingdom Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 199. United Kingdom Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 200. Netherlands Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 201. Netherlands Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 202. Netherlands Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 203. Rest of Europe Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 204. Rest of Europe Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 205. Rest of Europe Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 206. MEA Diagnostic Technology, by Country USD Million (2023-2028)
  • Table 207. MEA Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 208. MEA Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 209. MEA Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 210. Middle East Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 211. Middle East Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 212. Middle East Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 213. Africa Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 214. Africa Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 215. Africa Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 216. North America Diagnostic Technology, by Country USD Million (2023-2028)
  • Table 217. North America Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 218. North America Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 219. North America Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 220. United States Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 221. United States Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 222. United States Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 223. Canada Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 224. Canada Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 225. Canada Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 226. Mexico Diagnostic Technology, by Type USD Million (2023-2028)
  • Table 227. Mexico Diagnostic Technology, by Application USD Million (2023-2028)
  • Table 228. Mexico Diagnostic Technology, by End User USD Million (2023-2028)
  • Table 229. Research Programs/Design for This Report
  • Table 230. Key Data Information from Secondary Sources
  • Table 231. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Diagnostic Technology: by Type USD Million (2017-2022)
  • Figure 5. Global Diagnostic Technology: by Application USD Million (2017-2022)
  • Figure 6. Global Diagnostic Technology: by End User USD Million (2017-2022)
  • Figure 7. South America Diagnostic Technology Share (%), by Country
  • Figure 8. Asia Pacific Diagnostic Technology Share (%), by Country
  • Figure 9. Europe Diagnostic Technology Share (%), by Country
  • Figure 10. MEA Diagnostic Technology Share (%), by Country
  • Figure 11. North America Diagnostic Technology Share (%), by Country
  • Figure 12. Global Diagnostic Technology share by Players 2022 (%)
  • Figure 13. Global Diagnostic Technology share by Players (Top 3) 2022(%)
  • Figure 14. Global Diagnostic Technology share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Roche Diagnostics SpA (Italy) Revenue, Net Income and Gross profit
  • Figure 17. Roche Diagnostics SpA (Italy) Revenue: by Geography 2022
  • Figure 18. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 20. Abbott Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Abbott Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 22. Siemens AG (United States) Revenue, Net Income and Gross profit
  • Figure 23. Siemens AG (United States) Revenue: by Geography 2022
  • Figure 24. Sysmex Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 25. Sysmex Corporation (Japan) Revenue: by Geography 2022
  • Figure 26. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 27. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 28. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 29. Becton, Dickinson, and Company (United States) Revenue: by Geography 2022
  • Figure 30. Biomérieux SA (France) Revenue, Net Income and Gross profit
  • Figure 31. Biomérieux SA (France) Revenue: by Geography 2022
  • Figure 32. Bio-Rad Laboratories, Inc. (France) Revenue, Net Income and Gross profit
  • Figure 33. Bio-Rad Laboratories, Inc. (France) Revenue: by Geography 2022
  • Figure 34. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 35. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 36. Global Diagnostic Technology: by Type USD Million (2023-2028)
  • Figure 37. Global Diagnostic Technology: by Application USD Million (2023-2028)
  • Figure 38. Global Diagnostic Technology: by End User USD Million (2023-2028)
  • Figure 39. South America Diagnostic Technology Share (%), by Country
  • Figure 40. Asia Pacific Diagnostic Technology Share (%), by Country
  • Figure 41. Europe Diagnostic Technology Share (%), by Country
  • Figure 42. MEA Diagnostic Technology Share (%), by Country
  • Figure 43. North America Diagnostic Technology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Roche Diagnostics SpA (Italy)
  • Danaher Corporation (United States)
  • Abbott Laboratories, Inc. (United States)
  • Siemens AG (United States)
  • Sysmex Corporation (Japan)
  • Thermo Fisher Scientific (United States)
  • Becton, Dickinson, and Company (United States)
  • Biomérieux SA (France)
  • Bio-Rad Laboratories, Inc. (France)
  • Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Diagnostic Technology Pty. Ltd. (Australia) , Agilent Technologies (United States) , QIAGEN GmbH (Germany) , Diasorin S.p.A (Italy) , Ortho Clinical Diagnostics (A Part of Carlyle Group) (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 150 Pages 78 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Diagnostic Technology Market Quantitative research analysis
Global Diagnostic Technology Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Diagnostic Technology Market are Roche Diagnostics SpA (Italy), Danaher Corporation (United States), Abbott Laboratories, Inc. (United States), Siemens AG (United States), Sysmex Corporation (Japan), Thermo Fisher Scientific (United States), Becton, Dickinson, and Company (United States), Biomérieux SA (France), Bio-Rad Laboratories, Inc. (France) and Johnson & Johnson (United States) etc.
Infectious Diseases segment in Global market to hold robust market share owing to "Rising Geriatric Population ".

Know More About Global Diagnostic Technology Market Report?

Have a Query? Click Here

Other Related Reports

Heart Failure Therapeutics - Comprehensive Study by Type (Diagnosis, Prognosis), Application (Hospital, Clinic, Medical Research Organization) Players and Region - Global Market Outlook to 2030
$ 3500
Oligodendroglioma Treatment Comprehensive Study by Treatment Type Names (Surgery, Radiotherapy, Chemotherapy), Type of Oligodendroglioma (Pure Oligodendroglioma, Mixed Oligodendroglioma), Grade Type ...
$ 3350
Cervical Cancer Comprehensive Study by Type (Squamous cell carcinoma, Adenocarcinoma), Application (Hospitals, Cancer Palliative care clinics, Diagnostic centers, Pharmacies), Drug Type (Avastin (Bev...
$ 3750
Wound Care Treatments Comprehensive Study by Type (Surgical Wound Care Products, Advanced Wound Care Products, Traditional Wound Care Products), Application (Hospitals, Clinics, Home Care, Others), W...
$ 3350
Tinnitus Management Comprehensive Study by Type (Sound Masking Devices, Hearing Aids, Notched Music Devices, Cochlear Implant), Indication (Subjective Tinnitus, Objective Tinnitus), Distribution Chan...
$ 3450
Dravet Syndrome Treatment Comprehensive Study by Type (Clobazam (CLB in some regions),, As initial therapy,, Stiripentol (STP),, Cannabidiol (CBD), Or fenfluramine (FFA) as escalation therapies;), Ap...
$ 3650